Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. read more
Hung Do Ph.D. ā Chief Science Officer at Amicus Therapeutics
Executive Bio
Dr. Hung Do, Ph.D., has been the Chief Science Officer at Amicus Therapeutics, Inc. since July 2015 Dr. Do served as Senior Vice President of Discovery Biology for Amicus Therapeutics, Inc. since November 2013. Dr. Do co-founded Callidus Biopharma, Inc. and served as its Chief Executive Officer and Chief Scientific Officer. Dr. Do has nearly fifteen years of experience in the field of LSDs and ERTs while working at Novazyme, Genzyme, Amicus and Callidus. Dr. Do holds a Ph.D. in medical biochemistry and genetics from Texas A&M University and was a post-doctoral fellow in Hematology/Oncology at Emory University.
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Executive Team Culture Ratings from Amicus Therapeutics Employees
TOP
5%
Amicus Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Amicus TherapeuticsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Amicus TherapeuticsAmicus Therapeutics' Executive Team at a Glance
Based on 2 ratings, Amicus Therapeutics' employees are very satisfied with their Executive Team and give them an āA+ā or 90/100.
Amicus Therapeutics' Executive Team ranks in the Top 5% of other companies in New York and Top 5% of other companies on Comparably that also have 51-200 Employees.
×